Furthermore, just look at the chart and you can see this is going down into the new year. We're in a downtrend. No news means this downtrend continues on and we both know how quickly this can escalate. We can see 5%/day losses here. It's quite typical for AMBS, unfortunately.
Bro, I've been around here much longer than you have and have not once been called a basher. Stating that there will be no news before end of the year is not ripping or bashing a stock.
However, I must keep in mind that the big run last year happened around this time, although it happened on no news. I just don't see why big G would release news end of year knowing that it's traditionally not a time when people take new long positions.
before year end will probably see this head back to .04 and I wouldn't be surprised to see some end of year selling for tax purposes to pull this into .03s. Hope not, but this is AMBS we're talkin' 'bout.
I think he's going to need more news than that to get the share price up and above .10 for 20 consecutive days. There needs to be a serious fundamental shift in the conscience of AMBS investors to look at it as more of a hold and not a flip. We've seen this entire past year that the only share price that this can seem to hold is .04. Any moves above this and it eventually falls back. We need some serious news that shows this company is legit and see a multi day run that turns into a multi month run well over .10, otherwise any news that sends this to .10 and then exhausts itself out will be a failure. Anything other than blockbuster news to get this onto a new level will be a failure, imo. I think Gerald knows what he's working against here. He sees how the share price gets pinned down. Hopefully him and the board of directors have some huge moves up their sleeves. I know all us longs are banking on seeing big moves this year. Anything less than that will see a lo dedicated longs walk.
I think so. I don't thing we'll see any big news to end off the year. I think any news that gives this is a pop would automatically result in a sell off end of year. Release something in January though, with a hint there is more to come and we'll probably see a sustained run. Just my thoughts.
I'd rather not see a Chairman's Blog. I think investors are getting impatient and are hungry for big news, not a Chairman's Blog. I personally like seeing them, as it keeps us all updated, but the share price always drops when G releases a Chairman's Blog. He can only talk about laying the foundation for 2014 so much. He needs to start delivering the goods, not talk about them coming.
Tell me about it. I don't understand why people can't just post logical facts and opinions, not just on AMBS, but any stock for that matter. None of us have a crystal ball.
From my experience being in this stock for over a year now, true longs have done their dd and are confident of what they own. .03-.04 range seems to be good support currently and I think most longs load up around that level. I also notice that most people that are bearish or short AMBS haven't done the full dd to know the potential we have here. I think they are looking at this as an OTC penny stock that has a history of being pumped and dumped.
Look at the science, the leadership, the transparency of the leadership and the board of advisors and directors and I'm confident that you'll see a stock that is worth owning. Upside is a lot larger than downside in my and many others opinions.
I think they'll reverse split 1:10 it at .25 or .50. Just a hunch with not much rationale.
Well, it's a very small cap bio company, trading on the OTC, in very early clinical stages with no source of revenue. It's speculation at this point although all signs are pointing towards short term success. Will it lead to long term success? Chances are very, very slim, but we could also be sitting on the next AMGEN, as some like to point out. Dr. Rubinfeld, one of the original partners of AMGEN, has said that AMBS potentially has the biggest discovery he's seen in his whole career. It could also be a massive failure though.
I think 2014 will be a big year for AMBS as they have a lot of things going on. Beyond 2014, it's really too hard to tell how it will all unfold. It's a speculative pharma. Your guess is as good as any of ours, even with solid due diligence performed.
The only reassuring thing is that the CEO continues to buy shares, even down here. Recent buy of 20k shares at 1.02. He probably could have waited for a bit lower.
That's what I keep telling myself. I pulled out of a number of stocks this year before they went on massive runs: GALE, CPRX, PLUG, INO, ZGNX, just to name a few. I plan on staying in this one as I think it could make moves bigger than any of those that I missed, if data is positive.
I just hope one of these possible scenarios comes to light soon. I can't help but feel a lot of investors are excited about the prospects but really want to see some hefty news come out soon. It's still a very speculative stock until we are shown reassurances to why we are here. Fluffy pr's and conferences are not going to do it.